One versus two breast density measures to predict 5- and 10-year breast cancer risk

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 6, 2015, Pages 889-897

  Kerlikowske, Karla ^a   Gard, Charlotte C ^b   Sprague, Brian L ^c   Tice, Jeffrey A ^a   Miglioretti, Diana L ^d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEW MEXICO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e CENTER FOR HEALTH STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST DENSITY; CANCER RISK; ETHNICITY; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; PRIORITY JOURNAL; RACE; RISK FACTOR; VITAL STATISTICS; BREAST; BREAST NEOPLASMS; CANCER REGISTRY; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; ETHNOLOGY; FOLLOW UP; INCIDENCE; MAMMOGRAPHY; PATHOLOGY; PROGNOSIS; RISK ASSESSMENT; STATISTICAL MODEL; UNITED STATES;

ADULT; AGED; BREAST; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MAMMOGRAPHY; MIDDLE AGED; MODELS, STATISTICAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84941761446     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0035     Document Type: Article

References (37)

1. American College of Radiology: The American College of Radiology Breast Imaging Reporting and Data System (BI-RADS). 4th ed. Reston, VA: American College of Radiology; 2003.
2. Tice JA, Cummings SR, Smith-Bindman R, Ichikawa L, Barlow WE, Kerlikowske K. Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model. Ann Intern Med 2008;148:337-47.
3. Barlow W, White E, Ballard-Barbash R, Vacek PM, Titus-Ernstoff LT, Carney PA, et al. A prospective breast cancer risk prediction model among women undergoing screening mammography. J Natl Cancer Inst 2006;98:1204-14.
4. Kerlikowske K, Grady D, Barclay J, Frankel S, Ominsky S, Sickles EA, et al. Variability and accuracy inmammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System (BIRADS). J Natl Cancer Inst 1998;90:1801-9.
5. Ciatto S, Houssami N, Apruzzese A, Bassetti E, Brancato B, Carozzi F, et al. Categorizing breast mammographic density: intra-and interobserver reproducibility of BI-RADS density categories. Breast 2005;14:269-75.
6. Spayne M,Gard C, Skelly J, Miglioretti D, Vacek P,Geller B. Reproducibility of BI-RADS breast density measures among community radiologists: a prospective cohort study. Breast J 2012;18:326-33.
7. Gard C, Bowles E, Miglioretti D, Taplin S, Rutter C. Misclassification of Breast Imaging Reporting and Data System (BI-RADS) mammographic density and implications for breast density reporting legislation. Breast J 2015;21:In Press.
8. Harvey J, Gard C, Miglioretti D, Yankaskas B, Kerlikowske K, Buist D, et al. Reported mammographic density: film-screen versus digital acquisition. Radiology 2013;266:752-8.
9. Kerlikowske K, Ichikawa L, Miglioretti D, Buist D, Vacek P, Smith-Bindman R, et al. Longitudinal measurement of clinical mammographic breast density improves estimation of breast cancer risk. J Natl Cancer Inst 2007; 99:386-95.
10. Cuzick J, Warwick J, Pinney E, Duffy SW, Cawthorn S, Howell A, et al. Tamoxifen-induced reduction inmammographic density and breast cancer risk reduction: a nested case-control study. J Natl Cancer Inst 2011;103: 744-52.
11. Kim J,Han W, Moon H, Ahn S, Shin H, You J, et al. Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in hormone receptor positive breast cancer. Breast Cancer Res 2012;14:R102.
12. Ballard-Barbash R, Taplin SH, Yankaskas BC, Ernster VL, Rosenberg RD, Carney PA, et al. Breast Cancer Surveillance Consortium: a national mammography screening and outcomes database. Am J Roetengol 1997; 169:1001-8.
13. Ernster V, Ballard-Barbash R, BarlowW, Zheng Y, Weaver D, Cutter G, et al. Detection of DCIS in women undergoing screeningmammography. J Natl Cancer Inst 2002;94:1546-54.
14. Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA 2014;311:1327-35.
15. Surveillance Epidemiology SEER Program: SEER∗Stat Database Version 8.1.2. Incidence-SEER 18 Regs Public-Use, Sub (2000-2010), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch; 2014 [accessed 2013 Dec 12 for invasive cancer and on 2014 Jan 13 for in situ cancers]. Available from: http://www.seer.cancer.gov.
16. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989; 81:1879-86.
17. Centers for Disease Control and Prevention: National Center for Health Statistics. Underlying Cause of Death 1999-2010 on CDC WONDER Online Database, released 2012. Data are from the Multiple Cause of Death Files, 1999-2010, as compiled from data provided by the 57 vital statistics jurisdictions through the Vital Statistics Cooperative Program; 2014 [accessed 2014 Jan 8]. Available from: http://wondercdcgov/ucdicd10html.
18. French B, Saha-Chaudhuri P, Ky B, Cappola TP, Heagerty PJ. Development and evaluation of multi-marker risk scores for clinical prognosis. Stat Methods Med Res 2012; published online July 5, 2012. doi: 10.1177/0962280212451881.
19. Pencina M, D'Agostino RS, D'Agostino RJ, Vasan R. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-72.
20. Cook N, Ridker P: Advances inmeasuring the effect of individual predictors of cardiovascular risk: The role of reclassificationmeasures. Ann Intern Med 2009;150:795-802.
21. Breslow NE. Discussion of Professor Cox's paper. J Royal Stat Soc B 1972; 34:216-7.
22. Heagerty PJ, Lumley T, PepeMS. Time-dependent ROC curves for censored curvival data and a diagnostic marker. Biometrics 2000;56:337-44.
23. Stone M. Cross-validatory choice and assessment of statistical predictions. J Roy Stat Soc B 1974;26:111-47.
24. Stone M. An asymptotic equivalence of choice of model by cross-validation and Akaike's criterion. J Roy Stat Soc B 1977;39:44-7.
25. Heagerty P, Saha P. survivalROC: time-dependent ROC curve estimation from censored survival data. R package version 1.0.3; 2013 [accessed 2014 Nov 18]. Available from: http://CRAN.R-project.org/package=survivalROC.
26. Gray B. cmprsk: Subdistribution analysis of competing risks. R package version 2.2-7 2014 [accessed 2014 Nov 18]. Available from: http://CRAN.R-project.org/package=cmprsk.
27. Vachon C, Pankratz V, Scott C, Haeberle L, Ziv E, Jensen M, et al. The contributions of breast density and common genetic variation to breast cancer risk. J Natl Cancer Inst 107, doi:10.1093/jnci/dju397.
28. Kerlikowske K, Zhu W, Tosteson A, Sprague B, Tice J, Lehman CD, et al. Identifying women with dense breasts at high risk of missed cancers. Ann Intern Med 2015, In press.
29. U.S. Preventive Services Task Force. Medications for Risk Reduction of Primary Breast Cancer in Women, Topic Page; 2013 [accessed 2015 Jan 2]. Available from: http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrpv.htm.
30. Bevers T, Armstrong D, Arun B, Carlson R, Cowan K, Daly M, et al. Breast cancer risk reduction. J Natl Compr Canc Netw 2010;8:1112-46.
31. Work M, Reimers L, Quante A, Crew K, Whiffen A, Terry M. Changes in mammographic density over time in breast cancer cases andwomenat high risk for breast cancer. Int J Cancer 2014;135:1740-4.
32. Li J, Humphreys K, Eriksson L, Edgren G, Czene K, Hall P. Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer. J Clin Oncol 2013;31:2249-56.
33. Sandberg M, Li J, Hall P, Hartman M, dos-Santos-Silva I, Humphreys K, et al. Change of mammographic density predicts the risk of contralateral breast cancer-a case-control study. Breast Cancer Res 2013;15:R57.
34. Roetzheim RG, Lee JH, Fulp W, Matos Gomez E, Clayton E, Tollin S, et al. Acceptance and adherence to chemoprevention among women at increased risk of breast cancer. Breast 2015;24:51-6.
35. Tyrer J, Duff SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Statist Med 2004;23:1111-30.
36. EvansD,Warwick J, Astley S, Stavrinos P, Sahin S, Ingham S, et al. Assessing individual breast cancer risk within the U.K. NationalHealth Service Breast Screening Program: a new paradigm for cancer prevention. Cancer Prev Res 2012;7:943-51.
37. Sickles EA, D'Orsi CJ, Bassett LW, Appleton CM, Berg WA, Burnside ES, et al. ACR BI-RADS Mammography. In: ACR BI-RADS Atlas, Breast Imaging Reporting and Data System. Reston, VA, American College of Radiology; 2013.